Lifely M R, Esdaile J, Moreno C
Department of Experimental Immunobiology, Wellcome Research Laboratories, Beckenham, Kent, UK.
Vaccine. 1989 Feb;7(1):17-21. doi: 10.1016/0264-410x(89)90005-4.
Pregnant rabbits vaccinated with meningococcal group B polysaccharide complexed to outer membrane proteins (serotype 6) responded to produce IgG, IgM and IgA anti-B polysaccharide antibodies, which were passively transferred to the offspring (IgG preferentially) and could be detected in their sera immediately after birth. These antibody levels were sustained in the mothers but diminished in the offspring to background levels at day 22 after birth. In a subsequent experiment, rabbits immunized with the group B vaccine had offspring that proved considerably more resistant to infection with Escherichia coli K1 than the control litters from non-immune mothers. Although not complete, protection was statistically of high significance and correlated well with the anti-B polysaccharide titres obtained in the mothers.
用与外膜蛋白复合的B群脑膜炎球菌多糖(血清型6)对怀孕兔子进行免疫接种后,兔子产生了IgG、IgM和IgA抗B多糖抗体,这些抗体(主要是IgG)被动转移给后代,且在后代出生后立即就能在其血清中检测到。这些抗体水平在母兔体内得以维持,但在后代中于出生后第22天降至背景水平。在随后的实验中,用B群疫苗免疫的兔子所产后代,相比未免疫母兔的对照窝仔,对大肠杆菌K1感染的抵抗力明显更强。虽然保护并不完全,但在统计学上具有高度显著性,且与母兔体内获得的抗B多糖滴度密切相关。